Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JAMA Dermatology|March 20, 2024
Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic ReviewSheila Shaigany, Nicole Mastacouris, Rachel Tannenbaum, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipientsMegan H Trager, Shana M Coley, Geoffrey Dube, et al.
Cancer Immunology Research|June 8, 2026
Cancer chemo-immunotherapy: time will tellSam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanomaJianda Yuan, Geoffrey Y Ku, Matthew Adamow, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy responseKranthi Kiran Kishore Tanagala, Joshua Morin-Baxter, Richard Carvajal, et al.
Cancer Research|April 24, 2023
Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in MelanomaHa-Ram Park, Anahita Shiva, Portia Cummings, et al.
JAMA Oncology|January 20, 2022
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging AnalysisLaurent Dercle, Binsheng Zhao, Mithat Gönen, et al.
The Oncologist|February 25, 2026
Computationally Assisted Patient Finding for Navigation to Optimize Pancreatic Cancer Care AccessDaniel A King, Kristen M John, Joseph Tenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumorsArchie N Tse, David S Klimstra, Mithat Gonen, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective studyYana G Najjar, Kristina Navrazhina, Fei Ding, et al.
Pageof 3